ribavirin has been researched along with Affective Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buljan, D; Gelo, J; Sakoman, LN; Sindik, I; Vrbanac, DB | 1 |
| Cozzolongo, R; Giannuzzi, V; Lanzilotta, E; Leandro, G; Porcelli, P | 1 |
| Anthony, DD; Bonomo, RA; Chandar, AK; Compan, A; Davitkov, P; Falck-Ytter, Y; Gideon, C; Hirsch, A; Silveira, MG; Smith, S | 1 |
| Blacklaws, H; Gardner, A; Usher, K | 1 |
| Fuchs, D; Schloegl, A; Schroecksnadel, S; Vogel, W; Zoller, H | 1 |
| Demetrashvili, MF; Liu, S; Manatunga, A; McNutt, MD; Miller, AH; Musselman, DL; Raison, CL; Royster, EB; Woolwine, BJ | 1 |
| Czarnecki, M; Gładysz, A; Inglot, M; Jańczak, G; Małyszczak, K; Pawłowski, T; Rymer, W | 1 |
| Bernard, PH; Castera, L; Champbenoit, P; Constant, A; Couzigou, P; De Ledinghen, V; Demotes-Mainard, J; Henry, C | 1 |
| Perry, CM; Scott, LJ | 1 |
2 review(s) available for ribavirin and Affective Disorders
| Article | Year |
|---|---|
Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferons; Mood Disorders; Ribavirin | 2011 |
Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Anemia, Hemolytic; Antiviral Agents; Clinical Trials as Topic; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Molecular Sequence Data; Mood Disorders; Recombinant Proteins; Ribavirin | 2002 |
3 trial(s) available for ribavirin and Affective Disorders
| Article | Year |
|---|---|
The role of alexithymia in quality of life impairment in patients with chronic hepatitis C during antiviral treatment.
Topics: Affective Symptoms; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Stress, Psychological | 2015 |
Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
Topics: Anemia; Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Drug Tolerance; Female; Hepatitis C; Hospitalization; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Oligopeptides; Proline; Ribavirin; Severity of Illness Index; Treatment Outcome | 2016 |
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antiviral Agents; Double-Blind Method; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Ribavirin; Time Factors; Treatment Outcome | 2012 |
4 other study(ies) available for ribavirin and Affective Disorders
| Article | Year |
|---|---|
Psychiatric aspects of hepatitis C treatment.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Mood Disorders; Ribavirin | 2013 |
Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio.
Topics: Adult; Biosynthetic Pathways; Chromatography, High Pressure Liquid; Female; Hepacivirus; Hepatitis, Chronic; Humans; Immunotherapy; Interferon-alpha; Male; Middle Aged; Mood Disorders; Phenylalanine; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Tyrosine; Viral Load | 2012 |
[Neuropsychiatric disorders in HCV-infected people--own observations].
Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Poland; Psychiatric Status Rating Scales; Quality of Life; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors; Treatment Outcome | 2005 |
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.
Topics: Antiviral Agents; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure | 2006 |